Frequent compartmentalization of hepatitis C virus with leukocyte-related amino acids in the setting of liver transplantation

Journal of Infectious Diseases

Volumn 198, Issue 11, 2008, Pages 1656-1666

  Schramm, Frédéric ^a,b   Soulier, Eric ^a,b   Royer, Cathy ^a,b   Weitten, Thierry ^a,b   Fafi Kremer, Samira ^a,b   Brignon, Nicolas ^a   Meyer, Nicolas ^a   Ellero, Bernard ^a   Woehl Jaegle, Marie Lorraine ^a   Meyer, Carole ^a   Wolf, Philippe ^a   Doffoë, Michel ^a   Baumert, Thomas F ^a,b   Stoll Keller, Françoise ^a,b   Schvoerer, Evelyne ^a,b,c  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CORTICOSTEROID; MYCOPHENOLIC ACID; RAPAMYCIN; TACROLIMUS;

ADULT; ARTICLE; CELL COMPARTMENTALIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC DISTANCE; GRAFT RECIPIENT; GRAFT REJECTION; HEPATITIS C VIRUS; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE; LIVER TRANSPLANTATION; MALE; MANTEL HAENSZEL TEST; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYLOGENY; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS ENTRY;

AMINO ACID SEQUENCE; AMINO ACIDS; EVOLUTION, MOLECULAR; GENETIC VARIATION; HEPACIVIRUS; HUMANS; LEUKOCYTES, MONONUCLEAR; LIVER TRANSPLANTATION; MOLECULAR SEQUENCE DATA; PHYLOGENY; SELECTION (GENETICS); VIRAL PROTEINS;

EID: 56649108118     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/592986     Document Type: Article

References (46)

1. Garcia-Retortillo M, Forns X, Feliu A, et al. Hepatitis C virus kinetics during and immediately after liver transplantation. Hepatology 2002; 35:680-7.
2. Martell M, Esteban JI, Quer J, et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 1992; 66:3225-9.
3. Schvoerer E, Soulier E, Royer C, et al. Early evolution of hepatitis C virus (HCV) quasispecies after liver transplant for HCV-related disease. J Infect Dis 2007; 196:528-36.
4. McCaughan GW, Zekry A. Mechanisms of HCV reinfection and allograft damage after liver transplantation. J Hepatol 2004; 40:368-74.
5. Radkowski M, Wang LF, Vargas HE, Rakela J, Laskus T. Detection of hepatitis C virus replication in peripheral blood mononuclear cells after orthotopic liver transplantation. Transplantation 1998; 66:664-6.
6. Laskus T, Radkowski M, Piasek A, et al. Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes. J Infect Dis 2000; 181:442-8.
7. Laskus T, Radkowski M, Jablonska J, et al. Human immunodeficiency virus facilitates infection/replication of hepatitis C virus in native human macrophages. Blood 2004; 103:3854-9.
8. Ducoulombier D, Roque-Afonso AM, Di Liberto G, et al. Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes. Hepatology 2004; 39:817-25.
9. Roque Afonso AM, Jiang J, Penin F, et al. Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets. J Virol 1999; 73:9213-21.
10. Blackard JT, Kemmer N, Sherman KE. Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology 2006; 44:15-22.
11. Roque-Afonso AM, Ducoulombier D, Di Liberto G, et al. Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells. J Virol 2005; 79:6349-57.
12. Scarselli E, Ansuini H, Cerino R, et al. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. Embo J 2002; 21:5017-25.
13. Barth H, Schafer C, Adah MI, et al. Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J Biol Chem 2003; 278:41003-12.
14. Tarr AW, Owsianka AM, Timms JM, et al. Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33. Hepatology 2006; 43:592-601.
15. Bartosch B, Verney G, Dreux M, et al. An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies. J Virol 2005; 79:8217-29.
16. Nakamoto Y, Kaneko S, Ohno H, et al. B-cell epitopes in hypervariable region 1 of hepatitis C virus obtained from patients with chronic persistent hepatitis. J Med Virol 1996; 50:35-41.
17. Neau D, Jouvencel AC, Legrand E, et al. Hepatitis C virus genetic variability in 52 human immunodeficiency virus-coinfected patients. J Med Virol 2003; 71:41-8.
18. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24:1596-9.
19. Poss M, Rodrigo AG, Gosink JJ, et al. Evolution of envelope sequences from the genital tract and peripheral blood of women infected with clade A human immunodeficiency virus type 1. J Virol 1998; 72:8240-51.
20. Crooks GE, Hon G, Chandonia JM, Brenner SE. WebLogo: a sequence logo generator. Genome Res 2004; 14:1188-90.
21. Schneider TD, Stephens RM. Sequence logos: a new way to display consensus sequences. Nucleic Acids Res 1990; 18:6097-100.
22. Blackard JT, Hiasa Y, Smeaton L, et al. Compartmentalization of hepatitis C virus (HCV) during HCV/HIV coinfection. J Infect Dis 2007; 195:1765-73.
23. Kondo Y, Sung VM, Machida K, Liu M, Lai MM. Hepatitis C virus infects T cells and affects interferon-gamma signaling in T cell lines. Virology 2007; 361:161-73.
24. Kessel A, Toubi E. Chronic HCV-related autoimmunity: a consequence of viral persistence and lymphotropism. Curr Med Chem 2007; 14:547-54.
25. Shimizu YK, Igarashi H, Kanematu T, et al. Sequence analysis of the hepatitis C virus genome recovered from serum, liver, and peripheral blood mononuclear cells of infected chimpanzees. J Virol 1997; 71:5769-73.
26. Nakajima N, Hijikata M, Yoshikura H, Shimizu YK. Characterization of long-term cultures of hepatitis C virus. J Virol 1996; 70:3325-9.
27. Di Liberto G, Roque-Afonso AM, Kara R, et al. Clinical and therapeutic implications of hepatitis C virus compartmentalization. Gastroenterology 2006; 131:76-84.
28. Martell M, Esteban JI, Quer J, et al. Dynamic behavior of hepatitis C virus quasispecies in patients undergoing orthotopic liver transplantation. J Virol 1994; 68:3425-36.
29. Feliu A, Gay E, Garcia-Retortillo M, Saiz JC, Forns X. Evolution of hepatitis C virus quasispecies immediately following liver transplantation. Liver Transpl 2004; 10:1131-9.
30. Hughes MG Jr, Rudy CK, Chong TW, et al. E2 quasispecies specificity of hepatitis C virus association with allografts immediately after liver transplantation. Liver Transpl 2004; 10:208-16.
31. Di Liberto G, Feray C. The anhepatic phase of liver transplantation as a model for measuring the extra-hepatic replication of hepatitis C virus. J Hepatol 2005; 42:441-3.
32. Dahari H, Forns X, Neumann AU, Perelson AS. The extrahepatic contribution to HCV plasma viremia. J Hepatol 2006; 45:626-7; author reply, 7-8.
33. Laskus T, Radkowski M, Wilkinson J, Vargas H, Rakela J. The origin of hepatitis C virus reinfecting transplanted livers: serum-derived versus peripheral blood mononuclear cell-derived virus. J Infect Dis 2002; 185:417-21.
34. Navarro F, Portales P, Candon S, et al. Natural killer cell and alphabeta and gammadelta lymphocyte traffic into the liver graft immediately after liver transplantation. Transplantation 2000; 69:633-9.
35. Kato K, Sato H, Takebe Y. Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism. J Virol 1999; 73:5520-6.
36. Korber B, Myers G. Signature pattern analysis: a method for assessing viral sequence relatedness. AIDS Res Hum Retroviruses 1992; 8:1549-60.
37. Penin F, Combet C, Germanidis G, Frainais PO, Deleage G, Pawlotsky JM. Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment. J Virol 2001; 75:5703-10.
38. Callens N, Ciczora Y, Bartosch B, et al. Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry. J Virol 2005; 79:15331-41.
39. Zeisel MB, Fafi-Kremer S, Fofana I, et al. Neutralizing antibodies in hepatitis C virus infection. World J Gastroenterol 2007; 13:4824-30.
40. Barth H, Liang TJ, Baumert TF. Hepatitis C virus entry: molecular biology and clinical implications. Hepatology 2006; 44:527-35.
41. Barth H, Schnober EK, Zhang F, et al. Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction. J Virol 2006; 80:10579-90.
42. Barth H, Ulsenheimer A, Pape GR, et al. Uptake and presentation of hepatitis C virus-like particles by human dendritic cells. Blood 2005; 105:3605-14.
43. Barth H, Schnober EK, Neumann-Haefelin C, et al. Scavenger receptor class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cells. J Virol 2008; 82:3466-79.
44. von Hahn T, Yoon JC, Alter H, et al. Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. Gastroenterology 2007; 132:667-78.
45. Gane EJ, Naoumov NV, Qian KP, et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996; 110:167-77.
46. Lindwasser OW, Chaudhuri R, Bonifacino JS. Mechanisms of CD4 downregulation by the Nef and Vpu proteins of primate immunodeficiency viruses. Curr Mol Med 2007; 7:171-84.